Oramed Pharmaceuticals Inc
Price
FilingsNewest: 8-K, Shareholder voteSep 17 →InsidersNo open-market buys or sales.→HoldersMercer Global Advisors INC /adv 9.2%Aquamarine Financial (Cayman) 6.1%Gem Investment 4.8%→PeersClosest companies: PPCB, GALT, HURA→
From the filings
Figures
- Revenue
- $2.0Mlast 12 months
- Net income
- $110.9Mlast 12 months
- Operating cash flow
- −$8.5Mlast 12 months
- Cash and equivalents
- $15.2Mat the last balance sheet
- Shares outstanding
- 41.3M shareson issue